Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. KS BioHistory (TM)
Career
Job Search Post a Job Destination KS
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: Athena Partners - Eliminating women's cancers
Events
 
Facilities
 

Earn a UW master’s or certificate in medical engineering or pharmaceutical bioengineering.

ORCA Annual Meeting Registration: Sept. 22 (PDF 165 kb) - Sign up now!


BioHistory Moment: Food Additives Amendments passed

Food Additives Amendments passed

On September 6, 1958, The Food Additives Amendments were passed, requiring that food additives, including preservatives, emulsifiers, and other functional additives, be subject to premarket testing.

Today, the FDA must review the safety of food and color additives before manufacturers and distributors can market them. To initiate this review, the FDA requires sponsors to submit a petition or notification that includes test data demonstrating the safety of the intended use of the substance.

More...

Learn about University of Iowa Research Park BioVentures Center

University of Iowa’s Oakdale Research Park. The Research Park/BioVentures Center, also known as the University of Iowa’s Oakdale Campus, is conveniently located on Highway 965 near Interstates 80 and 380 and U.S. Highways 16 and 218. The Park is in the fast-growing community of Coralville, about 10 minutes from the main UI campus of Iowa City, 15 minutes from commercial airlines at the Eastern Iowa Regional Airport in Cedar Rapids and 10 minutes from charter and corporate aircraft at the Iowa City Municipal Airport.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Kansas, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • MedImmune receives complete response letter on motavizumab   MedImmune announced that it has received a second complete response letter on motavizumab from the FDA which requested evidence from an additional clinical trial that supports a satisfactory risk/benefit profile in the population(s) for which the prophylaxis indication is being requested.
    MedImmune, LLC.  September 05, 2010  


  • UNMC enrollment reaches record high for sixth consecutive year  For the sixth straight year, student enrollment at the University of Nebraska Medical Center set a record high with 3,486 students enrolled for the 2010-11 school year -- an increase of 7.7 percent over last year's previous record total of 3,237.
    University of Nebraska Medical Center  September 03, 2010  


  • European Commission issues positive decision for approval of Seroquel XR  AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
    AstraZeneca  September 02, 2010  


  • New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test  New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
    Cepheid  September 02, 2010  


  • Allergan resolves investigation of past sales and marketing practices related to BOTOX(R)  Allergan announced a resolution with the U.S. Department of Justice regarding Allergan's past U.S. sales and marketing practices relating to therapeutic uses of BOTOX. Allergan pled guilty to a single misdemeanor "misbranding" charge covering the period 2000 through 2005 and will pay $375 million.
    Allergan, Inc.   September 01, 2010  


More... | Submit News Release | Advertising...

Novo Nordisk Banner Ad

New Job Postings...

Free Job Posting Trial Offer
  • Head of Medical Affairs Operations  Seattle Genetics, Inc. (WA)
  • Molecular & FISH Technologist CellNetix Pathology and Laboratories  (WA)
  • Research Technician I/II Benaroya Research Institute (WA)
  • Postdoctoral Research Associate Benaroya Research Institute (WA)
  • Animal Technician I Benaroya Research Institute (WA)
More... | Job Advertising... | About Job Postings...
Gilead - Careers for Life

New Facilities Available...

ATC clean room constructors...validation guaranteed!
  • 890 Embarcadero Road Property -- West Sacramento, CA
  • Icogenex Biotech Incubator -- Seattle, WA
  • Biotech and Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
UW Surplus

Upcoming Events...

  • 09/12/2010: 2010 Agricultural Biotechnology International Conference
  • 09/13/2010: The Future of Bio-Based Chemicals – Inception to Marketplace
  • 09/13/2010: SEB Food Security and Safety Symposium
  • 09/13/2010: ADAPT 2010
  • 09/13/2010: Biotechnology: Science for Managers
More... | Submit Event | Event Advertising...
EquipNet

Learn About Kansas's BioHistory

Learn About Kansas's BioHistory Why is there a life science industry in Kansas? Is the industry growing? What do other states have?

Through Kansas BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Kansas.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


September: Ovarian Cancer Awareness Month

Ovarian Cancer Awareness Month

In women age 35-74, ovarian cancer is the fifth leading cause of cancer-related deaths. An estimated one woman in 58 will develop ovarian cancer during her lifetime. The American Cancer Society estimates that in 2008, there will be 21,650 new cases of ovarian cancer and 15,520 women will die from ovarian cancer.

The National Ovarian Cancer Coalition (NOCC) is dedicated to raising awareness and increasing education about ovarian cancer. Established in 1995, the organization is committed to improving the survival rate and quality of life for women with this cancer.

More...


BioFact

(1979) - Seeds of the Earth, a book by Canadian economist Pat Mooney, is the first publication to warn of potential control of germplasm resources by the private sector, launching an international debate over the control and use of genetic resources.


It's a Small World

  Plant Cells Plant Cells  

Science Quote

" "It is unworthy of excellent men to lose hours like slaves in the labor of calculation which could be relegated to anyone else if machines were used.""

-  Gottfried Wilhelm von Leibnitz -German philosopher and mathematician
 (1646-1716)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

KansasLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the state of Kansas.